IndustryCompany release

Medicus Pharma regains Nasdaq equity compliance after equity raise and debt-for-preferred swap

🇺🇸 Medicus Pharma Ltd. (MDCX) · Thu 19 Nov 2026

Nasdaq says Medicus Pharma again meets the $2.5 million minimum shareholders' equity rule, but the company must prove it in its report for the period ending 31 December 2026.

Medicus Pharma (Nasdaq: MDCX) said Nasdaq notified it on 18 November 2026 that it has regained compliance with the minimum shareholders' equity requirement under Listing Rule 5550(b)(1), which sets a floor of $2.5 million.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Company's press release (SEC filing): Medicus Pharma Ltd. ↗

Article written by VigiEye from the official source (Medicus Pharma Ltd.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →